title: New initiatives against Africa's worms.
abstract: Since 1999, the funding available for the control of diseases of poverty (neglected diseases) has increased mainly due to leverage resulting from donations by the Bill and Melinda Gates Foundation and loans from the World Bank. Many countries have embarked on control programmes on a national scale due to drug donations by pharmaceutical companies through vertical programmes. The Schistosomiasis Control Initiative has expanded its operations to cover six countries in sub-Saharan Africa, but overlap of treatments between different vertical programmes is now a reality, and so care is needed to ensure that too many different drugs are not given together. Dialogue between programme managers has increased, and integration of some programmes may offer chances of synergy.
authors.affiliation: Schistosomiasis Control Initiative, Imperial College, Department of Infectious Disease Epidemiology, St Mary's Campus, Norfolk Place, London W2 1PG, UK. a.fenwick@imperial.ac.uk
authors.forename: Alan
authors.initials: A
authors.lastname: Fenwick
mesh_terms: D000349:Africa; D000871:Anthelmintics / Q000627:therapeutic use*; D002648:Child; D006373:Helminthiasis / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011223:Praziquantel / Q000627:therapeutic use*; D011314:Preventive Health Services / Q000458:organization & administration*; D012552:Schistosomiasis / Q000517:prevention & control* / Q000635:transmission
chemical_list: D000871:Anthelmintics; D011223:Praziquantel